Concepedia
Statistics
Publications
25
Citations
4K
H-Index
20
Active since
2001
Affiliations
University of Kentucky(Current)
Baylor College of Medicine
Markey Cancer Center
The University of Texas at San Antonio Health Science Center
Dan L Duncan Comprehensive Cancer Center
Suleiman Massarweh is an author at University of Kentucky specializing in medicine, oncology, and hormonal cancer therapy.
Publications per year
2001–2018
Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer
Jianzhong Shou, Suleiman Massarweh, C. K. Osborne et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
Suleiman Massarweh, C. Kent Osborne, Chad J. Creighton et al. · Cancer Research · 2008 · 494 citations
Medicine, Endocrinology, Pharmacology +17
Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance
Rachel Schiff, Suleiman Massarweh, Jiang Shou et al. · Clinical Cancer Research · 2004 · 465 citations
Medicine, Endocrinology, Oncology +14
Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer
C. Kent Osborne, Jiang Shou, Suleiman Massarweh et al. · Clinical Cancer Research · 2005 · 461 citations · Full text
Medicine, Endocrinology, Oncology +15
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.
Rachel Schiff, Suleiman Massarweh, Jiang Shou et al. · PubMed · 2003 · 308 citations
1–5 of 25